Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,215 | 1,537 | 1,306 | 987 | 627 |
| Cost of Goods | 827 | 1,032 | 633 | 471 | 18 |
| Gross Profit | 388 | 505 | 673 | 516 | 609 |
| Operating Expenses | 3,495 | 2,297 | -674 | 2,575 | 11 |
| Operating Income | -2,280 | -1,760 | 1,980 | -1,588 | 616 |
| Other Income | -1,750 | 578 | -130 | 641 | 749 |
| Pre-tax Income | -4,030 | -1,182 | 1,850 | -947 | 1,365 |
| Income Tax | N/A | N/A | N/A | N/A | 9 |
| Net Income Continuous | -4,038 | -1,182 | 1,850 | -947 | 1,358 |
| Net Income Discontinuous | -26 | -430 | -789 | -1,476 | -4,211 |
| Net Income | $-4,064 | $-1,612 | $1,061 | $-2,423 | $-2,853 |
| EPS Basic Total Ops | -2.99 | -1.18 | 0.78 | -1.78 | 0.85 |
| EPS Basic Continuous Ops | -2.96 | -0.87 | 1.36 | -0.70 | 4.49 |
| EPS Basic Discontinuous Ops | -0.02 | -0.32 | -0.58 | -1.08 | -3.65 |
| EPS Diluted Total Ops | -2.99 | -1.18 | 0.78 | -1.78 | 0.85 |
| EPS Diluted Continuous Ops | -2.96 | -0.87 | 1.36 | -0.70 | 4.49 |
| EPS Diluted Discontinuous Ops | -0.02 | -0.32 | -0.58 | -1.08 | -3.65 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.87 | 0.78 | N/A | N/A |
| EBITDA(a) | $-2,176 | $-1,664 | $2,160 | $-1,360 | $838 |